Lorus Therapeutics Reports Results for Fiscal Year 2010

TORONTO, ONTARIO–(Marketwire – Aug. 30, 2010) – Lorus Therapeutics Inc. (TSX:LOR)(OTCBB:LRUSF) (“Lorus” or the “Company”) a biopharmaceutical company specializing in the research and development of pharmaceutical products and technologies for the management of cancer, today reported financial results for twelve months ended May 31, 2010. Unless specified otherwise, all amounts are in Canadian …